Erratum to: Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study

Erratum to: Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control... Clin Drug Investig (2017) 37:889–890 DOI 10.1007/s40261-017-0551-y ERRATUM Erratum to: Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study Yuri Aleksandrovich Karpov On behalf of the FORTISSIMO physicians Published online: 10 July 2017 Springer International Publishing AG 2017 Erratum to: Clin Drug Investig 2017; 37:207–217 DOI 10.1007/s40261-016-0479-7 In the original version, the Page 211, Fig. 1, Y-axis was labelled incorrectly. Below is the corrected version of Fig. 1. The online version of the original article can be found under doi:10.1007/s40261-016-0479-7. & Yuri Aleksandrovich Karpov Yuri_Karpov@inbox.ru Russian Cardiological Research and Production Complex, 3rd Cherepkovskaya st. 15A, Moscow 121552, Russia 890 Y. A. Karpov Fig. 1 Systolic and diastolic blood pressure reduction with single-pill Results are presented for the overall population (a) and diabetic combination perindopril/indapamide 10/2.5 mg in patients with patients (b). p \ 0.00001 vs. previous visit uncontrolled hypertension despite previous antihypertensive therapy. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Drug Investigation Springer Journals

Erratum to: Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study

Loading next page...
 
/lp/springer_journal/erratum-to-full-dose-perindopril-indapamide-in-the-treatment-of-rPuia7o1sP
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Pharmacotherapy; Pharmacology/Toxicology; Internal Medicine
ISSN
1173-2563
eISSN
1179-1918
D.O.I.
10.1007/s40261-017-0551-y
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial